Effect of atorvastatin on kidney function in chronic kidney disease: A randomised double-blind placebo-controlled trial
- 1 November 2010
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 213 (1), 218-224
- https://doi.org/10.1016/j.atherosclerosis.2010.07.053
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Focused Atorvastatin Therapy in Managed-Care Patients With Coronary Heart Disease and CKDAmerican Journal of Kidney Diseases, 2009
- Pravastatin and cardiovascular risk in moderate chronic kidney diseaseAtherosclerosis, 2009
- The Lipid lowering and Onset of Renal Disease (LORD) Trial: A randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney diseaseBMC Nephrology, 2008
- Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trialsBMJ, 2008
- Effects of Statins on Renal FunctionMayo Clinic Proceedings, 2007
- Expressing the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate with Standardized Serum Creatinine ValuesClinical Chemistry, 2007
- Statins for Improving Renal OutcomesJournal of the American Society of Nephrology, 2006
- A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney diseaseAmerican Journal of Kidney Diseases, 2003
- Impact of Treatment of Dyslipidemia on Renal Function, Fat Deposits and Scarring in Patients with Persistent Nephrotic SyndromeNephron, 2002
- Effect of lipid reduction on the progression of renal disease: A meta-analysisKidney International, 2001